A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT06863961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Patients With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy and safety of Afimkibart (also known as RO7790121) in participants with moderate to severe atopic dermatitis (AD).
Study identification
- NCT ID
- NCT06863961
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 162 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2025 (Actual)
- Primary completion
- Jul 22, 2026 (Actual)
- Completion
- Jan 30, 2027 (Estimated)
- Last update posted
- Aug 10, 2026
2025 – 2027
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Center for Dermatology Clinical Research | Fremont | California | 94538 | — |
| UCLA Division of Dermatology | Los Angeles | California | 90024 | — |
| Dermatology Research Associate | Los Angeles | California | 90045 | — |
| AMR Fort Myers | Fort Myers | Florida | 33912 | — |
| Olympian Clinical Research | Tampa | Florida | 33615 | — |
| Hamilton Research, LLC | Alpharetta | Georgia | 30022 | — |
| Dermatology Affiliates Research Institute, LLC | Atlanta | Georgia | 30305 | — |
| Dawes Fretzin Clinical Res LLC | Indianapolis | Indiana | 46250 | — |
| Southern Indiana Clinical Trials | New Albany | Indiana | 47150 | — |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | — |
| Regents of the University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Care Access Research - Hoboken | Hoboken | New Jersey | 07030 | — |
| Forest Hill Dermatology Group | Kew Gardens | New York | 11415 | — |
| Weill Cornell Medicine | New York | New York | 10075 | — |
| Centricity Research Columbus Dermatology | Columbus | Ohio | 43213 | — |
| Central Sooner Research | Oklahoma City | Oklahoma | 73170 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Best Skin Research LLC | Camp Hill | Pennsylvania | 17011 | — |
| Arlington Research Center | Arlington | Texas | 76011 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| Reveal Research Institute | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06863961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06863961 live on ClinicalTrials.gov.